OTC •
Healthcare •
Drug Manufacturers - General •
Quote as of 09/09/2026 16:00
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeOTC
Market Capitalization33,300 mln
Float1,820 mln
Earnings Date10/30/2026
EPS
0.88
Moderate
P / E
19.95
Moderately valued
Beneish M-Score
-2.25
Borderline
Relative Strength
44
/ 100
Slightly lagging
Debt / Equity
0.29
Very low leverage
Pre-Tax Margin
11%
Moderate margin
Business Description
Daiichi Sankyo is a Japanese pharmaceutical company founded in 1899 and headquartered in Tokyo, with operations across the United States, Europe, and other global markets. The company develops and sells a broad range of medicines covering cancer, heart disease, diabetes, bone health, pain, and neurological conditions, along with vaccines for illnesses such as influenza and COVID-19. Among its best-known products are Enhertu, a cancer treatment used for several HER2-positive tumor types, and a growing portfolio of drugs targeting blood disorders, iron deficiency, and migraine. The company also works with outside partners to advance research and improve how new treatments are discovered and developed.
